The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Likely drop below 5p so rather snap them up on the open market
There we have it, considering 5p placing RNS
If someone told us 12 months ago that we would have HUA on the LFT and AVA dose escalation news with a second preCISION candidate selected for development and we would have a SP of 90p............we would be laughing ourselves silly.
Excited for the future but come on!!
Come on
Well done Bline, reduced my avg to a little over the placing price now so happy enough. It has been a good opportunity, we hope
Blackcat, like you many of us are underwater but many of us invest with emotion, greed and risk under check.
Anyone who re-mortgages a house or gets into serious debt to 'play' the markets does indeed need help. I hope for your sake, AVA comes good and we climb north together
+11% just now (AVCT too)
I am gobsmacked we are still only valued at £33M
Pleased with the figures but we just need a year without COVID interruptions (don't we all)
Here's a question; if there is something requiring putting out an RNS during a suspension period, is it still a requirement to publish said news or is it allowed to wait until relisting?
Obviously great to see some positive news and this will become a huge milestone should it progress, however, it is clearly an attempt to stop the declining share price
Hoping for a 6.7% when we start trading again.........or maybe 67% would be better ; D
Nobody knows, it would be pure guess work and speculation.
Sounds like FCA approval of the prospectus is the main hurdle which could be a lengthy process.
Chris Jeffries, CEO of Dev Clever, commented, "We are working closely with the FCA and our professional advisers to finalise the prospectus which is at an advanced stage, and look forward to our shares relisting as soon as possible in the new year.
Don't know about you guys but I am missing our beloved DEV. With the majority of my PF on it's knees, I could do with some good news and a return to global domination, or at least a steady trickle north.
HNY all
Yeah, GDR also stating no impact on their product. Everyone will be quick to not be tarred with the same proverbial brush
Never thought I would ever see my original buy-in price again.....getting very close. A sad day indeed
This is extremely disappointing to hear. I have been bleating on to anyone that will listen about AffiDX and how much better it is than the Chinese tosh
Possibly because they knew about this latest curve ball and thought it a pointless bit of news considering the decision they were mulling over
Great News? Really? Another delay, and this time to all sales
They are replacing the antibody
Yeah we’ve had flowflex for quite a while now which is nasal only. You get a shorted swap